Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApplied Nutrition PLC Regulatory News (APN)

Share Price Information for Applied Nutrition PLC (APN)

Share Price is delayed by 15 minutes
Get Live Data
298.50    4.50 (1.53%)
Bid:
295.50
Ask:
296.50
Spread: 1.00 (0.338%)
Market Cap: £746.25m
APN Live PriceLast checked at - London Stock Exchange

Intraday Applied Nutrition PLC Share Chart

FY25 Trading Update

19 Aug 2025 07:00

RNS Number : 7968V
Applied Nutrition PLC
19 August 2025
 

19 August 2025 

 Applied Nutrition plc

(the "Group")

FY25 Trading Update and FY26 Outlook

FY251 results ahead of market expectations2: revenue up c.24% and adjusted EBITDA3 up c.19% year-on-year

 

Applied Nutrition plc, a leading sports nutrition, health and wellness brand, today announces an update on trading for the financial year ending 31 July 20251 and outlook for the financial year ending 31 July 20264.

 

FY251 Trading Update

 

Driven by strong second-half trading (approximately £60m of revenue), Group revenue is expected to be ahead of market expectations2, with revenue up 24% year-on-year to approximately £107 million (FY24: £86 million) and adjusted EBITDA3 up approximately 19% year-on-year (FY24: £26m). Net cash (excluding IFRS 16 liabilities) at the end of period is also expected to be ahead of market expectations2 at approximately £18.5 million.

 

The results for FY25 were achieved by the continued delivery of the Group's multi-pillar, global growth strategy.

 

FY26 Outlook4

 

Following the strong recent trading and supported by the strategic progress, the Group now expects revenue for the financial year ending 31 July 2026 to be ahead of current market expectations2.

 

The Board remains confident that the Group's core strengths, including its B2B-focused business model, breadth of high-quality products and industry leading new product development, will continue to drive sustained revenue growth and strong profitability over the long-term.

 

Notice of Results

 

The Group expects to release its results for the year ended 31 July 2025 on, or around, 10 November 2025.

 

Thomas Ryder, CEO of Applied Nutrition, said:

 

"We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations. Our focus and ambition remain as strong as ever - in delivering for our shareholders, customers and team - and we are excited about the opportunities we have in the pipeline for the year ahead."

 

Notes:

1 All figures used in this announcement relating to FY25 remain subject to audit.

2 Consensus market expectations for FY25 and FY26 before today were:

Measure

FY25

FY26

Revenue

£100.0 million

£112.4 million

Net cash

£16.6 million

£31.5 million

 

3 Adjusted EBITDA excludes exceptional items. The only exceptional items are expected to relate to the Group's Initial Public Offering ("IPO") during FY25.

4 This announcement contains certain forward-looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Accordingly undue reliance should not be placed on forward looking statements.

For further information please contact:

Applied Nutrition plc Thomas Ryder, Chief Executive OfficerSteven Granite, Chief Operating OfficerJoe Pollard, Chief Financial Officer

Via Alma

Alma Strategic Communications (Public Relations adviser to Applied Nutrition plc)

Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

+44 (0) 203 405 0205

appliednutrition@almastrategic.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Applied Nutrition is Joe Pollard, Chief Financial Officer.

Notes to editors

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world's most trusted and innovative brand in the market.

Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand - Applied Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group sells over 100 different products.

Applied Nutrition's growth is fuelled by a market-leading product portfolio, created and largely manufactured in-house at its Knowsley, Liverpool headquarters by a team of industry experts. This end-to-end capability allows the Group to innovate at speed, refresh and enhance existing products and introduce new offerings that anticipate and respond to the latest consumer trends.

Applied Nutrition largely operates a global business-to-business (B2B) model, which has facilitated a low risk, highly cost-effective go-to-market strategy and has enabled strong, profitable growth in the UK, Europe and other international geographies. The business model and strategy has enabled the Group to become a fast-growing, highly profitable and cash generative global supplier in the sports nutrition, health and wellness market.

For further information, please visit www.appliednutritionplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDIGDBDGUI
Date   Source Headline
4th Jun 202612:44 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTrading Update, Acquisition and Collaboration
28th Apr 20264:20 pmRNSHolding(s) in Company
21st Apr 20262:16 pmRNSHolding(s) in Company
21st Apr 202610:40 amRNSHolding(s) in Company
20th Apr 202610:10 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSResults of Secondary Placing in Applied Nutrition
15th Apr 20264:40 pmRNSProposed Secondary Placing in Applied Nutrition
13th Apr 20264:47 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSInterim Results
13th Mar 202611:48 amRNSHolding(s) in Company
13th Mar 202611:48 amRNSHolding(s) in Company
17th Feb 20267:00 amRNSH1 FY26 Trading Update
29th Jan 20261:39 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSAppointment of Joint Broker
8th Jan 20261:28 pmRNSResult of AGM
23rd Dec 202510:09 amRNSHolding(s) in Company
23rd Dec 202510:09 amRNSHolding(s) in Company
19th Dec 202512:40 pmRNSHolding(s) in Company
19th Dec 202512:40 pmRNSHolding(s) in Company
19th Dec 202512:38 pmRNSHolding(s) in Company
19th Dec 202512:38 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNS-RLicensing agreement with Morrisons for food range
19th Dec 20257:00 amRNS-RLicensing agreement with Morrisons for food range
17th Dec 20256:00 pmRNSPRS REIT (The)
16th Dec 20254:57 pmRNSHolding(s) in Company
16th Dec 20252:05 pmRNSHolding(s) in Company
15th Dec 20253:39 pmRNSHolding(s) in Company
9th Dec 20259:44 amRNSHolding(s) in Company
9th Dec 20257:00 amRNSTrading Update
8th Dec 202512:08 pmRNSHolding(s) in Company
4th Dec 20259:27 amRNSHolding(s) in Company
3rd Dec 20259:35 amRNSHolding(s) in Company
1st Dec 20254:20 pmRNSHolding(s) in Company
27th Nov 20253:26 pmRNSAnnual Report and Accounts and Notice of AGM
27th Nov 202510:56 amRNSHolding(s) in Company
18th Nov 20255:01 pmRNSHolding(s) in Company
14th Nov 20251:03 pmRNSHolding(s) in Company
10th Nov 202511:50 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSFinal Results
6th Nov 202511:11 amRNSHolding(s) in Company
5th Nov 20254:50 pmRNSHolding(s) in Company
3rd Nov 20255:41 pmRNSHolding(s) in Company
3rd Nov 202511:09 amRNSHolding(s) in Company
31st Oct 20253:30 pmRNSHolding(s) in Company
27th Oct 20254:08 pmRNSHolding(s) in Company
24th Oct 202510:50 amRNSHolding(s) in Company
17th Oct 20255:15 pmRNSHolding(s) in Company
17th Oct 20251:12 pmRNSHolding(s) in Company
16th Oct 20253:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.